Pharmacology - chapter 40 - Immunosuppressants Flashcards
The immune activation cascade can be described as a three signal model. Discribe this signal pathway.
1 T cell triggering by CD3 receptor-antigen complex on surface of APC
2 Costimulation when CD80 and CD86 of APC bind T cell CD28.
3 Stimulation of T cell poliferation.
Why are several immunosuppressants usually used together in a regime of different drugs, rather than monotheraphy?
Because it’s beneficial to use several drugs at lower doses, rather than one at a higher dose. This is because this group of drugs are associated with severe toxicity when large doses are administered.
Three categories of immunosuppressive drugs, based on theri mechanism of action?
1 interfere with cytokine production or action
2 disrupt cell metabolism, preventing lymphocyte proliferation
3 mono-and polyclonal antibodies block T cell surface molecules.
- Enhances activity of NK cells.
- Attracts neutrophils and macrophages.
Which cytokine be dis?
IL-1
- induces proliferation of antigen-primed T cells
- enhances activity of NK cells.
Which cytokine can this be?
Yes, it is IL-2
- enhances activity of NK cells and macrophages.
- increases expression og MHC molecules.
- Enhances production og IgG2a.
Which cytokine?
Iterferon gamma
- cytotoxic effect on tumor cells.
- induces cytokine secretion in the inflammatory response.
Cytokine?
TNF-alpha
what is the role of IL-2 in immuno suppressive therapy?
it stimulates the proliferation of antigen-primed T helper cells which in turn produce more IL-2, IFN-gamma and TNF-alpha. These cytokines collectively activate NK cells, macrophages, cytotoxic T lymphocytes. Therefore, drugs that interfere with IL-2 production will dampen the immune response.
Cyclosporine, mechanism of action?
binds with cyclophilin to form a complex that binds with calcineurin, thus inhibiting the calcineurin pathway that activates NFATc(cytoplasmic Nuclear Factor of Activated T cells). NFATc is a transcription factor that codes for IL-2.
Cyclosporine, areas of use?
used to prevent rejection of kidney, liver and cardiac allogeneic transplants.
Cyclosporine, metabolism?
Cyclosporine is metabolized by CYP3A4. It is also a substrate for intestinal P-glycoprotein.
Cyclosporine, adverse effects?
Nephrotoxicity is the most common and important adverse effect of cyclosporine.
Drugs by which coadministration will increase the nephrotoxicity of cyclosporine?
1 drugs that can cause renal dysfunction - e.g. aminoglycoside antibiotyka.
2 Anti-inflammatory such as diclofenac, naproxen or sulindac that potentiate the nephrotoxicity of cyclosporine.
One type of diuretics one should not administer along with cyclosporine?
K+ - sparing diuretics, as patients are proned to become hyperkalemic.
Tacrolimus, mechanism of action?
Similar to that of cyclosporine, except Tacrolimus binds with FK-binding protein, another component of the calcineurin pathway.
Tacrolimus, pharmacokinetics?
Metabolized by CYP3A4/5 and is a substrate for P-glycoprotein.
Tcrolimus, adverse effects?
Nephrotoxicity and neurotoxicity. Development of post-transplant insulin dependent diabetes mellitus is a problem, particularily for black and hispanic patients.
Sirolimus, areas of use?
Used in kidney transplant, administered together with cyclosporine and corticosteroids.
Sirolimus-coated stents are inserted into cardiac vasculature to inhibit restenosis of blood vessels by reducing proliferation of endothelial cells.
Sirolimus, mechanism of action?
Sirolimus bind with mTOR, interfering with signal 3: preventing IL-2 signal to induce T cell proliferation and thereby preventing activated T cell from entering S phase.